We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
I am a...
In the Spring 2022 Edition of Myeloma Today, IMF Chief Medical Officer Dr. Joseph Mikhael writes about bispecific antibodies—a unique combination of two strategies: a monoclonal antibody that targets myeloma cells and induces the immune system to destroy it; and a monoclonal antibody that engages a local immune cell to directly kill the myeloma cell. He also speaks about its many advantages as compared to other humoral and cellular approaches, such as dual treatment, “off the shelf,” different targets, and broader use. To learn more about bispecific antibodies, read the full publication of the 2022 Spring Edition of Myeloma Today.
The Brian D. Novis Research Grants was established in 1995 to honor IMF co-founder Brian D. Novis, who succumbed to multiple myeloma in July 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2022 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline to submit applications is on September 1, 2022.
The IMF Regional Community Workshop – Midwest was held on Saturday, May 21. IMF Senior Director of Regional Community Workshops Kelly Cox kicked off the workshop. Guest speakers included Morie Gertz, MD (Mayo Clinic—Rochester, MN), Al-Ola Abdallah, MD (University of Kansas Medical Center—Kansas City, KS), and IMF Nurse Leadership Board (NLB) Member Teresa Miceli, RN, BSN, OCN (Mayo Clinic—Rochester, MN). In case you missed it, you can still watch the replay.
The IMF Patient and Family Webinar on “New Frontiers in Myeloma Care” was held on Saturday, May 14. IMF Chairman Dr. Brian G.M. Durie moderated presentations with the following myeloma experts: Yi Lin, MD, PhD (Mayo Clinic—Rochester, MN), IMF Nurse Leadership Board Member Ann McNeill RN, MSN, APN (John Theurer Cancer Center, Hackensack University Medical Center—Hackensack, NJ), and Nikhil Munshi, MD (Dana-Farber Cancer Institute—Boston, MA). The webinar concluded with a summary panel discussion, a webinar survey, and closing remarks. In case you missed it, you can still watch the replay.
Our hearts go to all innocent victims of the ongoing conflict in Ukraine.
As a global organization, the International Myeloma Foundation supports — and will continue to support — every myeloma patient, caregiver, doctor, researcher, and advocate going through struggles and difficulties brought about by the war in Ukraine.
As an advocate for hope and resilience among the members of the myeloma community, the IMF is here for you — and even to a greater degree, during this most difficult time.
Our mission is clear, and our steadfast commitment continues — to improve the quality of life of myeloma patients across the globe, while working toward prevention and a cure.
Need assistance in creating a fundraiser? The IMF team is here for you. Find out how you can help in the fight against myeloma today!
